Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

519.55INR
6:26am EDT
Change (% chg)

Rs13.10 (+2.59%)
Prev Close
Rs506.45
Open
Rs509.00
Day's High
Rs524.70
Day's Low
Rs506.00
Volume
677,507
Avg. Vol
556,940
52-wk High
Rs792.20
52-wk Low
Rs433.15

Latest Key Developments (Source: Significant Developments)

Beijing Science Sun Pharmaceutical to buy 45 pct stake in Beijing Protein Innovation
Thursday, 15 Jun 2017 03:05am EDT 

June 15(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> ::* Says it will buy 45 percent stake in Beijing Protein Innovation no less than 22 million yuan.  Full Article

Sun Pharmaceutical Industries says US FDA approval for generic zetia tablets
Monday, 12 Jun 2017 10:44pm EDT 

June 13 (Reuters) - Sun Pharmaceutical Industries Ltd :Says Sun Pharma announces US FDA approval for generic zetia tablets.Says generic ezetimibe tablets are therapeutic equivalents of Merck's Zetia® tablets.  Full Article

Sun Pharma may have single digit decline in consol revenue for FY 18 vs FY 17 - exec
Friday, 26 May 2017 09:07am EDT 

May 26 (Reuters) - Sun Pharmaceutical Industries Ltd :Dilip Shanghvi says may have single digit decline in consol revenue for FY 18 versus FY 17.Dilip Shanghvi says "FY18 is likely to be a challenging year for us".Dilip Shanghvi says co took $45 million u.s. Inventory related charge in Q4 that is unlikely to be recurring.Dilip Shanghvi says co awaiting FDA inspection on Halol, unaware of FDA’s stance on the facility.Dilip Shanghvi says value of first-to-file products even during exclusivity is likely to go down.  Full Article

India's Sun Pharmaceutical Industries March-qtr consol profit down about 14 pct
Friday, 26 May 2017 07:16am EDT 

May 26 (Reuters) - Sun Pharmaceutical Industries Ltd :March quarter consol net profit 12.24 billion rupees.Consensus forecast for March quarter consol profit was 14.95 billion rupees.March quarter consol total revenue from operations 71.37 billion rupees.Consol net profit in March quarter last year was 14.16 billion rupees as per Ind-AS; consol total revenue from operations was 76.54 billion rupees.Recommended dividend of 3.50 rupees per share.Says reappointment of Dilip Shanghvi as MD.Says resignation of Uday Baldota as CFO.  Full Article

Sun Pharma announces fda filing acceptance of Biologics License Application for tildrakizumab
Wednesday, 24 May 2017 08:03am EDT 

May 24 (Reuters) - Sun Pharmaceutical Industries Ltd : :Sun Pharma announces U.S. FDA filing acceptance of Biologics License Application (bla) for tildrakizumab.  Full Article

Sun Pharma says US FDA files acceptance of BLA for Tildrakizumab
Wednesday, 24 May 2017 12:55am EDT 

May 24 (Reuters) - Sun Pharmaceutical Industries Ltd :Says US FDA filing acceptance of biologics license application (BLA) for Tildrakizumab.Says Tildrakizumab is investigational IL-23P19 inhibitor evaluated for treatment of moderate-to-severe plaque psoriasis..  Full Article

Beijing Science Sun Pharmaceutical to pay div of 2.5 yuan/10 shares for 2016
Tuesday, 25 Apr 2017 10:47pm EDT 

April 26(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:* Says it will pay dividend of 2.5 yuan/10 shares for 2016.  Full Article

Hunan China Sun Pharma Machinery unit signs partnership framework agreement on gene detection project
Thursday, 20 Apr 2017 10:08pm EDT 

April 21(Reuters) - Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> ::* Says its unit signed a partnership framework agreement with Changsha county local health bureau, to provide service for gene detection project for hypertensive patients .  Full Article

Hunan China Sun Pharma Machinery to pay annual cash div as 0.6 yuan per 10 shares for FY 2016
Wednesday, 19 Apr 2017 02:42am EDT 

April 19(Reuters) - Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> : :* Says it plans to pay annual cash dividend as 0.6 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Hunan China Sun Pharma Machinery sees Q1 FY 2017 net profit up 0 to 30 pct
Tuesday, 11 Apr 2017 01:30am EDT 

Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> : Sees Q1 FY 2017 net profit to increase by 0 to 30 percent, or to be 18.6 million yuan to 24.2 million yuan . Says Q1 FY 2016 net profit was 18.6 million yuan .The reason for the forecast is increased income of intelligent hybrid packing automatic production line.  Full Article

BRIEF-Sun Pharmaceutical Industries says unit gets U.S. FDA nod for new label for odomzo (sonidegib)

* Says one of co's units received approval from U.S. FDA for new label for odomzo (sonidegib) Source text - http://bit.ly/2f8WIsa Further company coverage: